Continuation Protocol for Obstructive Sleep Apnea (OSA)
NCT06566820
·
clinicaltrials.gov ↗
PHASE3
Phase
ENROLLING_BY_INVITATION
Status
1280
Enrollment
INDUSTRY
Sponsor class
Conditions
OSA
Interventions
DRUG:
Aroxybutynin and Atomoxetine
Sponsor
Apnimed